Guidelines for monitoring heparin by the activated clotting time when aprotinin is used during cardiopulmonary bypass
J Thorac Cardiovasc Surg
.
1992 Jul;104(1):211-2.
Authors
B J Hunt
,
H C Segal
,
M Yacoub
PMID:
1377315
No abstract available
Publication types
Comment
Letter
MeSH terms
Aprotinin / pharmacology*
Blood Coagulation / drug effects*
Cardiopulmonary Bypass*
Heparin / therapeutic use*
Humans
Whole Blood Coagulation Time*
Substances
Heparin
Aprotinin